Back to Search
Start Over
2016 guideline strategies for the use of antifungal agents in patients with hematological malignancies or hematopoietic stem cell transplantation recipients in Taiwan
- Source :
- Journal of Microbiology, Immunology and Infection, Vol 51, Iss 3, Pp 287-301 (2018)
- Publication Year :
- 2018
- Publisher :
- Elsevier, 2018.
-
Abstract
- The Infectious Diseases Society of Taiwan (IDST), the Hematology Society of Taiwan, the Taiwan Society of Blood and Marrow Transplantation, Medical Foundation in Memory of Dr. Deh-Lin Cheng, Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education, and CY Lee's Research Foundation for Pediatric Infectious Diseases and Vaccines cooperatively published this guideline for the use of antifungal agents in hematological patients with invasive fungal diseases (IFDs) in Taiwan. The guideline is the first one endorsed by IDST focusing on selection of antifungal strategies, including prophylaxis, empirical (or symptom-driven) and pre-emptive (or diagnostic-driven) strategy. We suggest a risk-adapted dynamic strategy and provide an algorithm to facilitate decision making in population level as well as for individual patient. Risk assessment and management accordingly is explicitly emphasized. In addition, we highlight the importance of diagnosis in each antifungal strategy among five elements of the antimicrobial stewardship (diagnosis, drug, dose, de-escalation and duration). The rationale, purpose, and key recommendations for the choice of antifungal strategy are summarized, with concise review of international guidelines or recommendation, key original articles and local epidemiology reports. We point out the interaction and influence between elements of recommendations and limitation of and gap between evidences and daily practice. The guideline balances the quality of evidence and feasibility of recommendation in clinical practice. Finally, this version introduces the concept of health economics and provides data translated from local disease burdens. All these contents hopefully facilitate transparency and accountability in medical decision-making, improvements in clinical care and health outcomes, and appropriateness of medical resource allocation.
- Subjects :
- 0301 basic medicine
Diagnosis-driven strategy
Antifungal Agents
lcsh:QR1-502
Symptom-driven strategy
lcsh:Microbiology
Antimicrobial Stewardship
0302 clinical medicine
Definitive therapy
Epidemiology
Immunology and Allergy
Antimicrobial stewardship
Medicine
030212 general & internal medicine
Risk assessment
Hematopoietic Stem Cell Transplantation
General Medicine
De-escalation
Infectious Diseases
Hematologic Neoplasms
Pediatric Infectious Disease
Accountability
Therapeutic algorithm
Antifungal strategy
Algorithms
Health economic
Microbiology (medical)
medicine.medical_specialty
030106 microbiology
Clinical Decision-Making
Taiwan
Guidelines as Topic
03 medical and health sciences
Humans
Antifungal stewardship
Intensive care medicine
book
Health economics
General Immunology and Microbiology
business.industry
Prophylaxis
Guideline
Antibiotic Prophylaxis
Preemptive therapy
Empirical therapy
book.journal
business
Delivery of Health Care
Invasive Fungal Infections
Subjects
Details
- Language :
- English
- ISSN :
- 16841182
- Volume :
- 51
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Journal of Microbiology, Immunology and Infection
- Accession number :
- edsair.doi.dedup.....6aab1afbd452c47bd68e751f149ce161